Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12136745 | 0.96 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL339880 | 0.91 | ESR1 (0.39) | ESR1ESR2 | |
| SCHEMBL6547160 | 0.89 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL6546676 | 0.89 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL6547559 | 0.89 | ESR1 (0.38) | ESR1ESR2 | |
| SCHEMBL18094270 | 0.88 | ESR1 (0.32) | ESR1ESR2 | |
| SCHEMBL12136768 | 0.83 | — | — | |
| SCHEMBL26973343 | 0.81 | ESR1 (0.33) | ESR1ESR2 | |
| SCHEMBL9715929 | 0.80 | ESR1 (0.35) | ESR1ESR2 | |
| SCHEMBL22660801 | 0.80 | ESR1 (0.35) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | claimed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | claimed |
| US-20040197284-A1 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| EP-3558222-B1 | WATER-IN-OIL EMULSION COMPRISING A PARTICULAR EMULSIFYING SYSTEM, A LIPOPHILIC CLAY, AND AN ORGANOPOLYSILOXANE ELASTOMER POWDER COATED WITH A SILICONE RESIN | OREAL (FR) | 2024-04-03 | — | — | EP | disclosed |
| EP-3558238-B1 | COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL | OREAL (FR) | 2023-08-23 | — | — | EP | disclosed |
| CN-110087609-B | Water-in-oil emulsion containing baicalin, xanthine base, vitamin B3, and polyvalent metal cation salt | 莱雅公司 | 2022-11-15 | — | — | CN | disclosed |
| US-11376205-B2 | Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt | L'OREAL (FR) | 2022-07-05 | — | — | US | disclosed |
| CN-110099662-B | Water-in-oil emulsion comprising a specific emulsifying system, a lipophilic clay and a silicone resin-coated organopolysiloxane elastomer powder | 莱雅公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-3558216-B1 | WATER-IN-OIL EMULSION CONTAINING BAICALIN, A XANTHINE BASE, A VITAMIN B3, AND A POLYVALENT METAL CATION SALT | L'ORÉAL (FR) | 2020-09-16 | — | — | EP | disclosed |
| US-10653600-B2 | Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and two particular distinct silicone oils | L'OREAL (FR) | 2020-05-19 | — | — | US | disclosed |
| US-20200085723-A1 | COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID beta,beta-DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL | L'OREAL (FR) | 2020-03-19 | — | — | US | disclosed |
| US-20130136705-A1 | COSMETIC COMPOSITION COMPRISING AN OIL AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2013-05-30 | — | — | US | disclosed |
| US-8440211-B2 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2013-05-14 | — | — | US | disclosed |
| US-20120234196-A1 | Viscous Liquid Monopropellant | PLANETARY SYSTEMS CORPORATION | 2012-09-20 | — | — | US | disclosed |
| EP-1620068-B1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | OREAL (FR) | 2012-05-09 | — | — | EP | disclosed |
| EP-2380556-A1 | Cosmetic composition comprising a volatile fatty phase | L'Oréal (FR) | 2011-10-26 | — | — | EP | disclosed |
| US-20090074689-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL S.A. | 2009-03-19 | — | — | US | disclosed |
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | disclosed |
| US-20040197284-A1 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10653600-B2 | Cosmetic composition comprising a supramolecular compound capable of establishing hydrogen bonds, and two particular distinct silicone oils | CHEK1, STIM1, FASN | ESR1 1919/4885ESR2 3623/4885 |
| US-20130136705-A1 | COSMETIC COMPOSITION COMPRISING AN OIL AND A POLYMER BOTH BEARING A HYDROGEN-BOND-GENERATING JOINING GROUP, AND COSMETIC TREATMENT PROCESS | SQLE, MMS19, FDFT1 | ESR1 3072/4885ESR2 3880/4885 |
| US-11376205-B2 | Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt | KRT18, BROX, S100B | ESR1 4223/4885ESR2 4346/4885 |
| US-20200085723-A1 | COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID beta,beta-DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL | KRT18, CUTA, SKP1 | ESR1 3821/4885ESR2 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.